Literature DB >> 7702409

Gout: questions that still need to be answered.

R A Terkeltaub1.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7702409      PMCID: PMC1005523          DOI: 10.1136/ard.54.2.79

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  20 in total

1.  Comparison of uricase-bound and uricase-loaded erythrocytes as bioreactors for uric acid degradation.

Authors:  M Magnani; U Mancini; M Bianchi; A Fazi
Journal:  Adv Exp Med Biol       Date:  1992       Impact factor: 2.622

Review 2.  Colchicine, crystals, and neutrophil tyrosine phosphorylation.

Authors:  J I Smallwood; S E Malawista
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

Review 3.  The adhesion molecules of inflammation.

Authors:  B N Cronstein; G Weissmann
Journal:  Arthritis Rheum       Date:  1993-02

4.  Rapid acceleration of neutrophil apoptosis by tumor necrosis factor-alpha.

Authors:  Y Takeda; H Watanabe; S Yonehara; T Yamashita; S Saito; F Sendo
Journal:  Int Immunol       Date:  1993-06       Impact factor: 4.823

5.  Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity.

Authors:  R Terkeltaub; C L Banka; J Solan; D Santoro; K Brand; L K Curtiss
Journal:  Arterioscler Thromb       Date:  1994-01

6.  Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model.

Authors:  E Ortiz-Bravo; M S Sieck; H R Schumacher
Journal:  Arthritis Rheum       Date:  1993-09

7.  Crystal-induced neutrophil activation. IV. Specific inhibition of tyrosine phosphorylation by colchicine.

Authors:  C J Roberge; M Gaudry; R de Médicis; A Lussier; P E Poubelle; P H Naccache
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  Ligand-induced activation of chimeric receptors between the erythropoietin receptor and receptor tyrosine kinases.

Authors:  H Ohashi; K Maruyama; Y C Liu; A Yoshimura
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

9.  Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes.

Authors:  Y Geng; B Zhang; M Lotz
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

10.  Inhibition of crystal-induced neutrophil activation by a protein tyrosine kinase inhibitor.

Authors:  H M Burt; J K Jackson; H Salari
Journal:  J Leukoc Biol       Date:  1994-01       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.